Search results for " Patients"

showing 10 items of 729 documents

The concept of a surrogate is ill adapted to intensive care: Criteria for recognizing a reference person

2016

IF 2.445; International audience; Purpose: In the intensive care unit (ICU), caregivers may find it difficult to identify a suitable person in the patient's entourage to serve as a reference when there is no official surrogate.Methods: We developed a 12-item questionnaire to identify factors potentially important for caregivers when identifying a reference person. Each criterion was evaluated as regards its importance for the role of reference. Responses were on a scale of 0 (not important) to 10 (extremely important). We recorded respondent's age, job title, and number of years' ICU experience. The questionnaire was distributed to all health care professionals in 2 French ICUs.Results: Amo…

AdultMaleUnit patientsDesignationCritical CareMedical informationDecision MakingPatient AdvocacyCritical Care and Intensive Care MedicinePatient advocacylaw.inventionYoung Adult03 medical and health sciences0302 clinical medicineNursinglawPhysiciansSurveys and QuestionnairesIntensive care[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyHealth careHumansMedicineYoung adultFamily-membersAgedResponse rate (survey)Ethicsbusiness.industryQuestionnaireSurrogate030208 emergency & critical care medicineMiddle AgedIntensive care unitProxy3. Good healthCaregivers030228 respiratory systemScale (social sciences)Intensive careRespondentSymptomsFemalebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data

2018

Background The X-ACT study aims to examine the effect of omalizumab treatment on quality of life (QoL) in chronic spontaneous urticaria (CSU) patients with angioedema refractory to high doses of H1-antihistamines. Methods In X-ACT, a phase III, double-blind, placebo-controlled study, CSU patients (18–75 years) with ≥4 angioedema episodes during the 6 months before inclusion were randomized (1:1) to receive omalizumab 300 mg or placebo every 4 weeks for 28 weeks. Angioedema-related QoL, skin-related QoL impairment, and psychological well-being were assessed. Results Ninety-one patients were randomized and 68 (omalizumab, n=35; placebo, n=33) completed the 28-week treatment period. At baselin…

AdultMalechronic spontaneous urticariamedicine.medical_specialtyAdolescentUrticariaImmunologyOmalizumab600 Technik Medizin angewandte Wissenschaften::610 Medizin und Gesundheit::616 KrankheitenPlaceboYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDouble-Blind MethodRefractoryQuality of lifeInternal medicine616Anti-Allergic AgentsmedicineHumansH1-antihistamine-refractoryImmunology and AllergyDepression (differential diagnoses)AgedAngioedemaAdult patientsbusiness.industryangioedemaDermatology Life Quality IndexMiddle AgedSurgeryquality of life030228 respiratory systemExperimental Allergy and ImmunologyomalizumabOriginal ArticleFemaleORIGINAL ARTICLESH1‐antihistamine‐refractorymedicine.symptombusinessmedicine.drugAllergy
researchProduct

Outcome of type III Gaucher disease on enzyme replacement therapy: review of 55 cases.

2007

The European Task Force for Neuronopathic Gaucher Disease (NGD) met in 2006 to review its 2001 guidelines. Fifty-five patients from five European countries were reviewed; 29 were male and 26 female. The majority of the patients were homozygous for the L444P mutation. All had been on enzyme replacement therapy (ERT). However, there was considerable variation in the dose of ERT, as well as an uneven distribution of risk factors. Thus, the oldest patients were on the lowest doses, and several had had a total splenectomy, while the youngest patients had a high proportion of compound heterozygosity and were on the highest doses, and very few had had a splenectomy. This heterogeneity rendered ana…

AdultMalecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyPediatricsHeterozygoteTime FactorsAdolescentmedicine.medical_treatmentSplenectomyEnzyme TherapyDiseaseCompound heterozygosityCentral nervous system diseaseOlder patientsRisk FactorsGeneticsmedicineTotal splenectomyHumansChildGenetics (clinical)Intelligence TestsChemotherapyGaucher Diseasebusiness.industryHomozygotenutritional and metabolic diseasesEnzyme replacement therapymedicine.diseaseSurgeryTreatment OutcomeChild PreschoolGlucosylceramidaseFemaleNervous System DiseasesbusinessJournal of inherited metabolic disease
researchProduct

A Prospective Randomized Study of Corticosteroids as Adjuvant Drugs to Opioids in Advanced Cancer Patients

2007

This randomized controlled study evaluated the role of corticosteroids as adjuvants to opioid therapy in 76 advanced cancer patients with pain who requiring strong opioids. Patients were divided in 2 groups. Group O received conventional opioid treatment. Group OS received dexamethasone (8 mg orally) along with conventional treatment. Pain and symptom intensity, sense of well-being, and opioid escalation index and distress score were recorded at weekly intervals until death. No differences in pain intensity, opioid consumption, and opioid escalation index were found in 66 patients who survived 33 to 37 days. Corticosteroids did not provide significant additional analgesia to opioids, but p…

AdultMalecorticosteroidmedicine.medical_treatmentAnti-Inflammatory Agentslaw.invention03 medical and health sciences0302 clinical medicinePharmacotherapyRandomized controlled trial030502 gerontologylawNeoplasmsmedicineHumansProspective Studiesopioids in advanced cancer patientsprospective randomized studyProspective cohort studyDexamethasoneAgedPain MeasurementAged 80 and overAnalysis of VarianceChemotherapyadjuvant drugDose-Response Relationship Drugbusiness.industryPalliative CareGeneral MedicineMiddle AgedPain IntractableAnalgesics OpioidTreatment OutcomeOpioidChemotherapy Adjuvant030220 oncology & carcinogenesisAnesthesiaDrug Therapy CombinationFemale0305 other medical scienceCancer painbusinessAdjuvantFollow-Up Studiesmedicine.drugAmerican Journal of Hospice and Palliative Medicine®
researchProduct

Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients

2011

Tacrolimus is a substrate of cytochrome P4503A (CYP3A) enzymes as well as of the drug transporter ABCB1. We have investigated the possible influence of CYP3A5 and ABCB1 single nucleotide polymorphisms (SNPs) and other factors (e.g. albumin, hematocrit and steroids) on tacrolimus blood levels achieved in a population of Caucasian liver (n=51) and kidney (n=50) transplant recipients. At 1, 3 and 6 months after transplantation, tacrolimus doses (mg/kg/day) and trough blood levels (C0) were recorded and the weight-adjusted tacrolimus dosage (mg/kg/day) was calculated. Polymerase chain reaction followed by restriction fragment length polymorphism analysis was used for genotyping CYP3A5*1 and *3 …

AdultMalemedicine.medical_specialtyATP Binding Cassette Transporter Subfamily BGenotypemedicine.medical_treatmentDNA Mutational AnalysisPopulationSingle-nucleotide polymorphismLiver transplantationBiologyKidneyPolymorphism Single NucleotideGastroenterologyBiomarkers PharmacologicalTacrolimusWhite PeopleGene FrequencyInternal medicineGeneticsmedicineCytochrome P-450 CYP3AHumansDrug Dosage CalculationsATP Binding Cassette Transporter Subfamily B Member 1educationAllele frequencyAllelesKidney transplantationAgededucation.field_of_studyKidney metabolismGeneral MedicineMiddle Agedmedicine.diseaseKidney TransplantationTacrolimusLiver TransplantationTransplantationsurgical procedures operativeItalyLiverImmunologySettore BIO/14 - FarmacologiaPharmacogenetics CYP3A5 ABCB1 TacrolimusTransplant patientsFemaleImmunosuppressive AgentsPolymorphism Restriction Fragment LengthInternational Journal of Molecular Medicine
researchProduct

Management of intralabyrinthine schwannomas

2006

Abstract Objectives Our protocol to manage the intralabyrinthine schwannoma (ILS). Methods Retrospective chart review of 7 consecutive patients managed for ILS. Results Five patients underwent surgical removal of the lesions and none experienced significant complications or recurrent disease. One patient refused surgical treatment and was closely followed by serial MRI scans with no signs of tumor growth. One patient is presently managed conservatively due to a good hearing. Conclusions Diagnosis of ILS is based on high resolution MRI scans and should be included in the differential diagnosis of patients investigated for cochleovestibular symptoms. Treatment modality of ILS is controversial…

AdultMalemedicine.medical_specialtyAcoustic neurinomaHearing lossLabyrinth DiseasesInner ear tumorPostoperative ComplicationsVestibular schwannomaOlder patientsVertigootorhinolaryngologic diseasesRecurrent diseaseHumansMedicineIntralabyrinthine schwannomaTumor growthIntralabyrinthine schwannomaEar NeoplasmsMeniere DiseaseRetrospective Studiesbiologybusiness.industryNeuroma AcousticGeneral MedicineMiddle Agedbiology.organism_classificationMagnetic Resonance ImagingSurgeryTreatment OutcomeOtorhinolaryngologyTreatment modalityEar InnerAudiometry Pure-ToneFemaleSurgeryDifferential diagnosismedicine.symptomAudiometry SpeechbusinessAuris Nasus Larynx
researchProduct

Joint involvement in psoriasis.

1974

21 unselected hospital patients with psoriasis (7 female, 14 males) were examined for joint lesions by clinical, roentgenological and scintigraphical methods (6 mCi99mTc-Pertechnetate, 4 mCi99mTc-Pyrophosphate). According to traditional concepts only 5 patients suffered from psoriatic arthropathy, in 8 other patients an extensive case history revealed some joint complaints.

AdultMalemedicine.medical_specialtyAdolescentArthritisDermatologyArthritis RheumatoidDiagnosis DifferentialPsoriatic arthritisPsoriasisArthropathymedicineHumansPsoriasisHospital patientsChildRadionuclide ImagingAgedSacroiliac jointArthritis Infectiousbusiness.industryFootArthritisTechnetiumSacroiliac JointGeneral MedicineMiddle Agedmedicine.diseaseHandDermatologySurgerymedicine.anatomical_structureJoint involvementHalluxFemaleJoint DiseasesbusinessJoint lesionsArchiv fur dermatologische Forschung
researchProduct

Post-traumatic trigeminal neuropathy. A study of 63 cases.

2010

Introduction. Trigeminal neuropathy is most often secondary to trauma. The present study explores the underlying causes and the factors that influence recovery. Material and methods. A retrospective case study was made involving 63 patients with trigeminal neuropathy of traumatologic origin, subjected to follow-up for at least 12 months. Results. Fifty-four percent of all cases were diagnosed after mandibular third molar surgery. In 37 and 19 patients the sensory defect was located in the territory innervated by the mental and lingual nerve, respectively. Pain was reported in 57% of the cases, and particularly among the older patients. Regarding patient disability, quality of life was not a…

AdultMalemedicine.medical_specialtyAdolescentTrigeminal neuropathyMandibular third molarYoung AdultQuality of lifeOlder patientsSensory defectMedicineHumansYoung adultGeneral DentistryLingual nerveAgedRetrospective Studiesbusiness.industryRetrospective cohort studyMiddle Aged:CIENCIAS MÉDICAS [UNESCO]SurgeryOrofacial Pain-TMJDOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryFemaleTrigeminal Nerve InjuriesResearch-ArticlebusinessMedicina oral, patologia oral y cirugia bucal
researchProduct

Are postural restrictions necessary for management of posterior canal benign paroxysmal positional vertigo?

2011

Objectives: An important component of management of benign paroxysmal positional vertigo (BPPV) has been the application of postural restrictions after use of a canalith repositioning maneuver (CRM) to prevent the return of otolithic debris into the posterior semicircular canal (PSC). This study was designed to explore the effectiveness of postural restrictions in patients with BPPV caused by otolithic debris in the PSC. Methods: Seventy-four adult patients with unilateral PSC BPPV were enrolled into this study. All patients were managed with a CRM — Either the modified Epley maneuver or the Semont maneuver. The patients were divided randomly into 2 groups: Group A, with postural restrictio…

AdultMalemedicine.medical_specialtyBenign paroxysmal positional vertigoAdolescentmedicine.medical_treatmentPostureEpley maneuverlaw.inventionSemont maneuverYoung AdultPhysical medicine and rehabilitationPosterior canal vertigoRandomized controlled triallawPostural restrictionRecurrenceVertigomedicineHumansEpley maneuverBenign Paroxysmal Positional VertigoProspective StudiesProspective cohort studyAgedSemont maneuverAged 80 and overAdult patientsbiologyPosterior Semicircular Canalbusiness.industryGeneral MedicineMiddle Agedmedicine.diseasebiology.organism_classificationBPPVSurgeryTreatment OutcomeOtorhinolaryngologyVertigoFemalebusinessThe Annals of otology, rhinology, and laryngology
researchProduct

Efect of periodontal disease and non surgical periodontal treatment on C-reactive protein. Evaluation of type 1 diabetic patients

2011

Objectives: The purpose of this study was to analyze how anti-infectious periodontal treatment affects C reactive protein (CRP) values in patients with type 1 diabetes, and correlate baseline CRP levels with periodontal disease severity. Study Design: A cohort of fifty three subjects with type 1 diabetes and moderate to severe periodontitis were recruited. Periodontal parameters were measured, and blood samples were obtained to evaluate high-sensitivity C-reactive protein (hs-CRP). Group 1 was treated with scaling, root planning, and systemic administration of doxycycline. Group 2 received only scaling and root planning. Results: Hs-CRP was reduced after periodontal treatment in group 1 (-0…

AdultMalemedicine.medical_specialtyCirurgia dentalDentistrySeverity of Illness IndexGastroenterologylaw.inventionRandomized controlled triallawInternal medicineDiabetes mellitusSeverity of illnessmedicineHumansSingle-Blind MethodPeriodontitisGeneral DentistryDoxycyclinePeriodontitisType 1 diabetesDiabetisbiologybusiness.industryC-reactive protein:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseC-Reactive ProteinDiabetes Mellitus Type 1OtorhinolaryngologyEstomatologiaUNESCO::CIENCIAS MÉDICASCohortbiology.proteinFemaleResearch-ArticleOdontostomatology for the Disabled or Special PatientsSurgerybusinessmedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct